-
27 Oct 2026
[Editorial] Sweating the details in exercise oncology
The Lancet Oncology
- Views 37
- More stats
-
27 Oct 2026
[Comment] Iberdomide for minimal residual disease-negative myeloma—from underdog to the spotlight
The Lancet Oncology
- Views 37
- More stats
-
27 Oct 2026
[Comment] Comprehensiveness of national cancer control plans
The Lancet Oncology
- Views 37
- More stats
-
27 Oct 2026
[Comment] The unfulfilled promise of effective cancer medicines priced beyond reach
The Lancet Oncology
- Views 43
- More stats
-
27 Oct 2026
[Comment] Rare earth elements and the fragile promise of cancer theranostics
The Lancet Oncology
- Views 33
- More stats
-
27 Oct 2026
[Correspondence] From biomarker actionability to surveillance utility in SERENA-6
The Lancet Oncology
- Views 44
- More stats
-
27 Oct 2026
[Correspondence] BCG-unresponsive non-muscle-invasive bladder cancer
The Lancet Oncology
- Views 31
- More stats
-
27 Oct 2026
[Correspondence] BCG-unresponsive non-muscle-invasive bladder cancer
The Lancet Oncology
- Views 30
- More stats
-
27 Oct 2026
[Correspondence] BCG-unresponsive non-muscle-invasive bladder cancer – Authors’ reply
The Lancet Oncology
- Views 34
- More stats
-
27 Oct 2026
[Corrections] Correction to Lancet Oncol 2025; 26: 898–910
The Lancet Oncology
- Views 20
- More stats
Journal Content
Life Science Network features journal content imported from some of the most popular scientific journals. In addition, the Publications module allows you to import or add your own publications to our database. Note that the indicated journal impact factors are not regularly updated.
Check the Publications module here
Advertisement